SCHEMBL20047031

SCHEMBL20047031

Cc1cc(I)cc(C)c1S(=O)(=O)N1CCc2cc(-c3cccc(C#N)c3)ccc2C1

nearest known ligand 0.48

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 5/20 0.48
AKR1C1 Q04828 2/20 0.48
HSD17B3 P37058 1/20 0.41
PAX8 Q06710 1/20 0.40
USP30 Q70CQ3 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
HRH3 Q9Y5N1 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
MCHR1 Q99705 2/20 0.39
CYP11B1 P15538 1/20 0.38
CYP11B2 P19099 1/20 0.38
ESR2 Q92731 1/20 0.37
LMNA P02545 1/20 0.37
OPRK1 P41145 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20047232 0.92 AKR1C3 (0.49) AKR1C3AKR1C1HSD17B3PAX8USP30
SCHEMBL20047021 0.91 AKR1C3 (0.45) AKR1C3AKR1C1HSD17B3USP30MEN1
SCHEMBL20047032 0.85 KMT2A (0.47) AKR1C3AKR1C1MEN1KMT2AL3MBTL1
SCHEMBL20047023 0.83 AKR1C3 (0.49) AKR1C3AKR1C1HSD17B3MEN1KMT2A
SCHEMBL20047231 0.82 AKR1C3 (0.47) AKR1C3AKR1C1HSD17B3USP30MEN1
SCHEMBL20047029 0.81 CYP11B1 (0.50) CYP11B1CYP11B2
SCHEMBL20047024 0.80 CHRM5 (0.41) AKR1C3AKR1C1MEN1KMT2AL3MBTL1
SCHEMBL20047027 0.79 PKM (0.51) AKR1C3AKR1C1USP30MEN1KMT2A
SCHEMBL20047020 0.79 MEN1 (0.40) AKR1C3AKR1C1MEN1KMT2AL3MBTL1
SCHEMBL22484651 0.79 L3MBTL1 (0.53) AKR1C3MEN1KMT2AL3MBTL1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017223514-A9 LXR INVERSE AGONISTS FOR TREATMENT OF CANCER SAINT LOUIS UNIVERSITY (US) 2018-04-12 WO disclosed